Search research articles
Contact Us
Filters
Showing results (201-210 of 212) with videos related to
Page
of 22
Sort By:
Pediatric Blood & Cancer
|
April 1, 2018
Phase I study of vorinostat in combination with isotretinoin in patients with refractory/recurrent neuroblastoma: A new approaches to Neuroblastoma Therapy (NANT) trial
Navin Pinto, Steven G DuBois, Araz Marachelian, et al.
Science Translational Medicine
|
November 19, 2025
Target antigen-displaying extracellular vesicles boost CAR T cell efficacy in cell and mouse models of neuroblastoma
Anna Maria Giudice, Stephanie Matlaga, Sydney L Roth, et al.
The New England Journal of Medicine
|
October 1, 2010
Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma
Alice L Yu, Andrew L Gilman, M Fevzi Ozkaynak, et al.
EMBO Molecular Medicine
|
May 18, 2013
ERBB4 confers metastatic capacity in Ewing sarcoma
Ariadna Mendoza-Naranjo, Amal El-Naggar, Daniel H Wai, et al.
Nature Communications
|
November 30, 2019
The targetable kinase PIM1 drives ALK inhibitor resistance in high-risk neuroblastoma independent of MYCN status
Ricky M Trigg, Liam C Lee, Nina Prokoph, et al.
Pediatric Blood & Cancer
|
October 27, 2006
The pediatric preclinical testing program: description of models and early testing results
Peter J Houghton, Christopher L Morton, Chandra Tucker, et al.
Pediatric Blood & Cancer
|
February 4, 2010
Toxicity assessment of molecularly targeted drugs incorporated into multiagent chemotherapy regimens for pediatric acute lymphocytic leukemia (ALL): review from an international consensus conference
Terzah M Horton, Richard Sposto, Patrick Brown, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 20, 2018
Broad Spectrum Activity of the Checkpoint Kinase 1 Inhibitor Prexasertib as a Single Agent or Chemopotentiator Across a Range of Preclinical Pediatric Tumor Models
Caitlin D Lowery, Michele Dowless, Matthew Renschler, et al.
Nature Biomedical Engineering
|
April 7, 2019
Antitumour activity and tolerability of an EphA2-targeted nanotherapeutic in multiple mouse models
Walid S Kamoun, Dmitri B Kirpotin, Zhaohua Richard Huang, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 15, 2025
Paediatric Strategy Forum for medicinal product development of agents targeting GD2 ganglioside in children and adolescents with cancer
Steven G DuBois, Lucas Moreno, Rochelle Bagatell, et al.
Page
of 22
Search research articles
Search
Showing results (201-210 of 212) with videos related to
Sort By:
Page
of 22
Pediatric Blood & Cancer
|
April 1, 2018
Phase I study of vorinostat in combination with isotretinoin in patients with refractory/recurrent neuroblastoma: A new approaches to Neuroblastoma Therapy (NANT) trial
Navin Pinto, Steven G DuBois, Araz Marachelian, et al.
Science Translational Medicine
|
November 19, 2025
Target antigen-displaying extracellular vesicles boost CAR T cell efficacy in cell and mouse models of neuroblastoma
Anna Maria Giudice, Stephanie Matlaga, Sydney L Roth, et al.
The New England Journal of Medicine
|
October 1, 2010
Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma
Alice L Yu, Andrew L Gilman, M Fevzi Ozkaynak, et al.
EMBO Molecular Medicine
|
May 18, 2013
ERBB4 confers metastatic capacity in Ewing sarcoma
Ariadna Mendoza-Naranjo, Amal El-Naggar, Daniel H Wai, et al.
Nature Communications
|
November 30, 2019
The targetable kinase PIM1 drives ALK inhibitor resistance in high-risk neuroblastoma independent of MYCN status
Ricky M Trigg, Liam C Lee, Nina Prokoph, et al.
Pediatric Blood & Cancer
|
October 27, 2006
The pediatric preclinical testing program: description of models and early testing results
Peter J Houghton, Christopher L Morton, Chandra Tucker, et al.
Pediatric Blood & Cancer
|
February 4, 2010
Toxicity assessment of molecularly targeted drugs incorporated into multiagent chemotherapy regimens for pediatric acute lymphocytic leukemia (ALL): review from an international consensus conference
Terzah M Horton, Richard Sposto, Patrick Brown, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 20, 2018
Broad Spectrum Activity of the Checkpoint Kinase 1 Inhibitor Prexasertib as a Single Agent or Chemopotentiator Across a Range of Preclinical Pediatric Tumor Models
Caitlin D Lowery, Michele Dowless, Matthew Renschler, et al.
Nature Biomedical Engineering
|
April 7, 2019
Antitumour activity and tolerability of an EphA2-targeted nanotherapeutic in multiple mouse models
Walid S Kamoun, Dmitri B Kirpotin, Zhaohua Richard Huang, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 15, 2025
Paediatric Strategy Forum for medicinal product development of agents targeting GD2 ganglioside in children and adolescents with cancer
Steven G DuBois, Lucas Moreno, Rochelle Bagatell, et al.
Page
of 22